Record Revenue Growth
Total net sales for Q3 2024 reached $38.9 million, marking a 44% increase compared to Q3 2023. This growth was driven by the addition of GAVRETO, which generated $7.1 million in net product sales.
Expanded International Presence
Rigel expanded its product presence outside the U.S. through a new agreement with Kissei to develop and commercialize REZLIDHIA in Japan, Korea, and Taiwan, including a $10 million upfront payment.
Strong Performance of TAVALISSE and REZLIDHIA
TAVALISSE shipped 2,797 bottles, a 16% increase from Q3 2023, while REZLIDHIA sales more than doubled with $5.5 million in net product sales.
Positive Net Income Achieved
Rigel achieved positive net income for the first time in the third quarter year-to-date, signaling strong financial performance and discipline.